{
    "title": "AstraZeneca admits sales have been hit by copycats as it beats off investor rebellion over boardroom pay",
    "url": "https://www.dailymail.co.uk/money/markets/article-3054421/AstraZeneca-admits-sales-hit-copycats-beats-investor-rebellion-boardroom-pay.html",
    "date": "2015-04-24",
    "keywords": [
        "cent",
        "share",
        "pay",
        "yesterday",
        "firm",
        "drug",
        "bid",
        "pfizer",
        "year",
        "astrazeneca",
        "partnership",
        "copycat",
        "investor",
        "rebellion",
        "boardroom",
        "paythe",
        "competition",
        "quarter",
        "blockbuster",
        "heartburn",
        "nexium",
        "market",
        "yearbut",
        "progress",
        "deal",
        "specialist",
        "celgene",
        "treatment",
        "blood",
        "report",
        "company",
        "management",
        "revenue",
        "defence",
        "takeover",
        "plc",
        "price",
        "money",
        "comcast",
        "time",
        "warner",
        "cable",
        "article",
        "manager",
        "richard",
        "buxton",
        "level",
        "takeoverhe",
        "pain",
        "spokesman",
        "strategy",
        "delivery",
        "controversy",
        "john",
        "lewis",
        "chairman",
        "charlie",
        "package",
        "increase",
        "bonus",
        "salary"
    ],
    "category": [
        "money",
        "markets"
    ]
}